Your browser doesn't support javascript.
loading
[68 Ga]Ga-PentixaFor: Development of a fully automated in hospital production on the Trasis miniAllinOne synthesizer.
Costes, Julien; Casasagrande, Kilian; Dubegny, Constance; Castillo, Juan; Kaufman, Jens; Masset, Julien; Vriamont, Charles; Warnier, Corentin; Faivre-Chauvet, Alain; Delage, Judith Anna.
Afiliación
  • Costes J; Radiopharmacy Unit, Department of Pharmacy, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Casasagrande K; Radiopharmacy Unit, Department of Pharmacy, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Dubegny C; Radiopharmacy Unit, Department of Pharmacy, Nantes University Hospital, Nantes, France.
  • Castillo J; Pentixapharm GmbH, Berlin, Germany.
  • Kaufman J; Pentixapharm GmbH, Berlin, Germany.
  • Masset J; Department of Research and Development, Trasis Radiopharmacy Instruments, Ans, Belgium.
  • Vriamont C; Department of Research and Development, Trasis Radiopharmacy Instruments, Ans, Belgium.
  • Warnier C; Department of Research and Development, Trasis Radiopharmacy Instruments, Ans, Belgium.
  • Faivre-Chauvet A; Nantes University, Nantes University Hospital, Inserm UMR 1307, CNRS UMR 6075, CRCI2NA, Nantes, France.
  • Delage JA; Radiopharmacy Unit, Department of Pharmacy, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
J Labelled Comp Radiopharm ; 66(12): 400-410, 2023 10.
Article en En | MEDLINE | ID: mdl-37679888
[68 Ga]Ga-PentixaFor is a frequently used radiotracer to image the CXCR4/CXCL12 axis in various malignancies, infections, and cardiovascular diseases. To answer increasing clinical needs, an automatized synthesis process ensuring efficient and reproducible production and improving operator's radioprotection is needed. [68 Ga]Ga-PentixaFor synthesis has been described on other synthesizers but not on the miniAiO. In this work, we defined automated synthesis process and an analytical method for the quality control of [68 Ga]Ga-PentixaFor. Validation batches were performed under aseptic conditions in a class A hotcell. All the quality controls required by the European Pharmacopea (Eur. Ph) were performed. The analytical methods were validated according to the International Conference Harmonization (ICH) recommendations. Validation batches were performed with a radiochemical yield of 94.8 ± 2.6%. All the quality controls were in conformity with the Eur. Ph, and the validation of the analytical method complied with the ICH. The environmental monitoring performed during the synthesis process showed that the aseptic conditions were ensured. [68 Ga]Ga-PentixaFor was successfully synthesized with the miniAiO by a fully automated process. This robust production mode and the quality control have been validated in this study allowing to increase the access of patients to this new promising radiopharmaceutical.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Complejos de Coordinación Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: J Labelled Comp Radiopharm Año: 2023 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Complejos de Coordinación Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: J Labelled Comp Radiopharm Año: 2023 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Reino Unido